Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Antimitotic KSP kinesin inhibitors in early development at Merck

Dec. 2, 2004

Serotonin reuptake inhibitors for treatment of affective disorders claimed in Lundbeck patents

Dec. 2, 2004

Vertex scientists describe novel protein kinase inhibitors

Dec. 2, 2004

A new method for the treatment of Parkinson's disease claimed by Newron

Dec. 2, 2004

Cilnidipine for the treatment of arrhythmia

Dec. 2, 2004

Antibacterial oxazolidinones claimed by Pfizer

Dec. 1, 2004

Novartis researchers describe beta2-adrenergic agonists

Dec. 1, 2004

Novel MAP kinase/TNF inhibitors in early development at Pfizer

Dec. 1, 2004

Dual acting compounds for the treatment of psychiatric disorders

Dec. 1, 2004

A series of protein tyrosine phosphatase inhibitors described in a patent

Dec. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...